Clump D A相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma

NI-RADS 2类在头颈部鳞状细胞癌首次治疗后FDG-PET/CT检查中的阴性预测值

期刊:American Journal of Neuroradiology

影响因子:3.7

doi:10.3174/ajnr.A5767

Wangaryattawanich, P; Branstetter, B F 4th; Hughes, M; Clump, D A 2nd; Heron, D E; Rath, T J

细胞生物学

发表日期：2018

文献求助收藏

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

一项针对局部晚期头颈癌患者的II期随机试验，比较了放射治疗、西妥昔单抗和培美曲塞联合或不联合贝伐珠单抗的疗效。

期刊:Annals of Oncology

影响因子:65.4

doi:10.1093/annonc/mdw204

Argiris, A; Bauman, J E; Ohr, J; Gooding, W E; Heron, D E; Duvvuri, U; Kubicek, G J; Posluszny, D M; Vassilakopoulou, M; Kim, S; Grandis, J R; Johnson, J T; Gibson, M K; Clump, D A; Flaherty, J T; Chiosea, S I; Branstetter, B; Ferris, R L

发表日期：2016

文献求助收藏

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

对高危头颈癌切除患者进行术后放疗联合顺铂加帕尼单抗治疗的 II 期试验

期刊:Annals of Oncology

影响因子:65.4

doi:10.1093/annonc/mdw428

Ferris R L, Geiger J L, Trivedi S, Schmitt N C, Heron D E, Johnson J T, Kim S, Duvvuri U, Clump D A, Bauman J E, Ohr J P, Gooding W E, Argiris A

发表日期：2016

文献求助收藏

Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation

经口机器人根治性手术与根治性放化疗治疗口咽鳞状细胞癌患者的肿瘤学结果和患者报告的生活质量

期刊:Oral Oncology

影响因子:3.9

doi:10.1016/j.oraloncology.2016.08.004

Ling, D C; Chapman, B V; Kim, J; Choby, G W; Kabolizadeh, P; Clump, D A; Ferris, R L; Kim, S; Beriwal, S; Heron, D E; Duvvuri, U

细胞生物学

发表日期：2016

文献求助收藏